A phase 1 study of collagenase clostridium histolyticum in patients with chronic plantar fasciitis demonstrated meaningful improvements in pain, function, and treatment satisfaction through day 84.
A post hoc analysis of a phase 2 trial found that collagenase clostridium histolyticum (CCH) significantly improved pain, function, and nodule characteristics in a selected subgroup of patients with plantar...
A study presented at American Podiatric Medical Association 2025 Annual Scientific Meeting explores how pain severity shapes daily burden, treatment experiences, and trial preferences among individuals...
